Liabilities / Assets
54th percentile
Higher debt load relative to assets than 54% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.09x
Liabilities / Revenue
78th percentile
Higher debt load relative to revenue than 78% of similar nonprofits.
Net Margin
10th percentile
Higher net margin than 10% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
13th percentile
Faster asset growth than 13% of similar nonprofits.
Revenue Growth
5th percentile
Faster revenue growth than 5% of similar nonprofits.
Balance Sheet
Assets
Down$1,902,421
Down $196,657 (-9.4%) from 2022
Net Assets
Down$1,725,591
Down $85,605 (-4.7%) from 2022
Liabilities
Down$176,830
Down $111,052 (-39%) from 2022
Revenue And Expenses
Revenue
Down$414,593
Down $479,235 (-54%) from 2022
Expenses
Down$562,349
Down $379,952 (-40%) from 2022
Net Income
Down-$147,756
Down $99,283 (-205%) from 2022
Historical Trend
Filing Detail Status
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2023 to Dec 31, 2023
Mission and Program Overview
Mission
The mission of ehe foundation is to seek treatments and a cure for epitheliod hemangioendofthelioma ehe by increasing awareness, pursuing scientific research, advocating for and supporting ehe patients and bridging information between researchers, providers and patients.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $1,902,421
- Liabilities
- $176,830
- Net assets
- $1,725,591
- Revenue
- $414,593
- Expenses
- $562,349
- Net income
- -$147,756